Article ; Online: Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination.
2023 Volume 129, Issue 6, Page(s) 895–896
Abstract: Recently, Liau et al. reported the results of Phase 3 clinical trial testing DCVax-L vaccines on patients with glioblastoma. Despite the promising and significant results obtained, the study design and the long-lasting period of recruitment of this work ... ...
Abstract | Recently, Liau et al. reported the results of Phase 3 clinical trial testing DCVax-L vaccines on patients with glioblastoma. Despite the promising and significant results obtained, the study design and the long-lasting period of recruitment of this work deserve some reflection. |
---|---|
MeSH term(s) | Humans ; Glioblastoma/therapy ; Brain Neoplasms/therapy ; Neoplasm Recurrence, Local/therapy ; Cancer Vaccines/therapeutic use ; Vaccination ; Dendritic Cells |
Chemical Substances | Cancer Vaccines |
Language | English |
Publishing date | 2023-02-15 |
Publishing country | England |
Document type | Controlled Clinical Trial ; Journal Article |
ZDB-ID | 80075-2 |
ISSN | 1532-1827 ; 0007-0920 |
ISSN (online) | 1532-1827 |
ISSN | 0007-0920 |
DOI | 10.1038/s41416-023-02194-1 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh III Zs.142: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.